Detalles de la búsqueda
1.
Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study.
Antimicrob Agents Chemother
; 65(9): e0123721, 2021 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34181475
2.
Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial.
Trials
; 22(1): 199, 2021 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33750432
3.
How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years.
BMJ Open
; 9(6): e029663, 2019 06 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31239309
4.
Insular cognitive impairment at the early stage of dementia with Lewy bodies: a preliminary study.
Geriatr Psychol Neuropsychiatr Vieil
; 15(3): 329-338, 2017 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28872044
5.
Lyme neuroborreliosis and dementia.
J Alzheimers Dis
; 41(4): 1087-93, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24762944
Resultados
1 -
5
de 5
1
Próxima >
>>